Statistics about Health, Pharma & Medtech in United States
Statistics
- Aeon Global Health Corp. liabilities 2015-2019
- Neogen net income 2019-2023
- Musclepharm revenue 2017-2021
- Aeon Global Health Corp. total assets 2015-2019
- Curis revenue 2019-2023
- Curis net cash 2019-2023
- Cardiff Oncology total equity 2019-2023
- Curis liabilities 2019-2023
- Curis operating profit 2019-2023
- Cardiff Oncology revenue 2019-2023
- Cardiff Oncology operating profit 2019-2023
- Cardiff Oncology liabilities 2019-2023
- Neurocrine Biosciences net income 2016-2018
- Molecular Templates, Inc. revenue 2011-2019
- Cardiff Oncology net cash 2019-2023
- Natures Sunshine Products Inc net income 2019-2023
- Molecular Templates, Inc. net income 2022-2023
- Navidea Biopharmaceuticals, Inc. net income 2018-2022
- Cti Biopharma Corp operating profit 2018-2022
- Cti Biopharma Corp net cash 2018-2022
- Cti Biopharma Corp total assets 2018-2022
- Morphic Holding total equity 2019-2023
- Moderna total equity 2019-2023
- Cti Biopharma Corp liabilities 2018-2022
- Cti Biopharma Corp total equity 2017-2021
- Cti Biopharma Corp revenue 2018-2022
- Cti Biopharma Corp net income 2018-2022
- Monopar Therapeutics total equity 2019-2023
- Natural Alternatives revenue 2020-2024
- Navidea Biopharmaceuticals, Inc. revenue 2018-2022
- Century Therapeutics total assets 2020-2023
- Natures Sunshine Products Inc gross profit 2019-2023
- Century Therapeutics revenue 2022-2023
- Century Therapeutics net income 2020-2023
- Neogen operating profit 2019-2023
- Neurocrine Biosciences operating profit 2019-2023
- Navidea Biopharmaceuticals, Inc. operating profit 2018-2022
- Natures Sunshine Products Inc operating profit 2019-2023
- Natural Alternatives operating profit 2020-2024
- Molecular Templates, Inc. operating profit 2019-2023
- Eliem Therapeutics total equity 2019-2023
- Nascent Biotech total equity 2019-2023
- Neogen gross profit 2019-2023
- Musclepharm operating profit 2017-2021
- Navidea Biopharmaceuticals, Inc. gross profit 2018-2022
- Century Therapeutics operating profit 2020-2023
- Century Therapeutics liabilities 2020-2023
- Akouos, Inc. liabilities 2019-2021
- Natural Alternatives gross profit 2020-2024
- Tango Therapeutics, Inc. revenue 2020-2023
- Musclepharm gross profit 2017-2021
- Neogen revenue 2019-2023
- Century Therapeutics net cash 2020-2023
- Neubase Therapeutics total equity 2018-2022
- Century Therapeutics total equity 2019-2023
- Ngm Biopharmaceuticals Inc net income 2019-2023
- Thorne Healthtech gross profit 2020-2022
- Neurocrine Biosciences revenue 2019-2023
- Akouos, Inc. operating profit 2019-2021
- Natures Sunshine Products Inc revenue 2019-2023
- Aeon Global Health Corp. net cash 2012-2019
- Aeon Global Health Corp. operating profit 2015-2019
- Ainos revenue 2019-2023
- Ainos net income 2011-2022
- Assembly Biosciences, Inc. net cash 2019-2023
- Arrowhead Pharmaceuticals, Inc. operating profit 2019-2023
- Adverum Biotechnologies, Inc. net cash 2019-2023
- Tourmaline Bio, Inc. liabilities 2020-2023
- Calidi Biotherapeutics net cash 2022-2023
- Theriva Biologics, Inc. liabilities 2019-2023
- Adverum Biotechnologies, Inc. total equity 2019-2023
- Calidi Biotherapeutics operating profit 2022-2023
- Arrowhead Pharmaceuticals, Inc. net income 2019-2023
- Tarsus Pharmaceuticals liabilities 2019-2023
- Tscan Therapeutics liabilities 2020-2023
- Clarus Therapeutics Holdings, Inc. gross profit 2020-2021
- Tourmaline Bio, Inc. net cash 2020-2023
- Theriva Biologics, Inc. net cash 2019-2023
- Clarus Therapeutics Holdings, Inc. revenue 2020-2021
- Molecular Templates, Inc. total equity 2019-2023
- Arrowhead Pharmaceuticals, Inc. revenue 2019-2023
- Adverum Biotechnologies, Inc. revenue 2019-2023
- Neogen total assets 2020-2024
- Arvinas total equity 2019-2023
- Arvinas liabilities 2019-2023
- Arvinas net cash 2019-2023
- Arvinas total assets 2019-2023
- Clarus Therapeutics Holdings, Inc. net income 2020-2021
- Clarus Therapeutics Holdings, Inc. net cash 2020-2021
- Arvinas revenue 2019-2023
- Arvinas operating profit 2019-2023
- Arvinas net income 2017-2021
- Neurocrine Biosciences total assets 2019-2023
- Nascent Biotech net income 2021-2023
- Artelo Biosciences total equity 2019-2023
- Artelo Biosciences total assets 2019-2023
- Adverum Biotechnologies, Inc. liabilities 2019-2023
- Musclepharm total equity 2017-2021
- Clarus Therapeutics Holdings, Inc. liabilities 2020-2021
- Calcimedica, Inc. liabilities 2019-2023